145 related articles for article (PubMed ID: 25896238)
1. Interleukin 34: a new modulator of human and experimental inflammatory bowel disease.
Zwicker S; Martinez GL; Bosma M; Gerling M; Clark R; Majster M; Söderman J; Almer S; Boström EA
Clin Sci (Lond); 2015 Aug; 129(3):281-90. PubMed ID: 25896238
[TBL] [Abstract][Full Text] [Related]
2. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease.
Autschbach F; Braunstein J; Helmke B; Zuna I; Schürmann G; Niemir ZI; Wallich R; Otto HF; Meuer SC
Am J Pathol; 1998 Jul; 153(1):121-30. PubMed ID: 9665472
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease.
Ślebioda TJ; Kmieć Z
Mediators Inflamm; 2014; 2014():325129. PubMed ID: 25045210
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory natural products modulate interleukins and their related signaling markers in inflammatory bowel disease: A systematic review.
Gandhi GR; Mohana T; Athesh K; Hillary VE; Vasconcelos ABS; Farias de Franca MN; Montalvão MM; Ceasar SA; Jothi G; Sridharan G; Gurgel RQ; Xu B
J Pharm Anal; 2023 Dec; 13(12):1408-1428. PubMed ID: 38223446
[TBL] [Abstract][Full Text] [Related]
5. Clinical importance of IL-22 cascade in IBD.
Mizoguchi A; Yano A; Himuro H; Ezaki Y; Sadanaga T; Mizoguchi E
J Gastroenterol; 2018 Apr; 53(4):465-474. PubMed ID: 29075900
[TBL] [Abstract][Full Text] [Related]
6. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B
Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973
[TBL] [Abstract][Full Text] [Related]
7. ATG16L1: A multifunctional susceptibility factor in Crohn disease.
Salem M; Ammitzboell M; Nys K; Seidelin JB; Nielsen OH
Autophagy; 2015 Apr; 11(4):585-94. PubMed ID: 25906181
[TBL] [Abstract][Full Text] [Related]
8. CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease.
Wendt E; Keshav S
Clin Exp Gastroenterol; 2015; 8():119-30. PubMed ID: 25897254
[TBL] [Abstract][Full Text] [Related]
9. IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization.
Ségaliny AI; Brion R; Brulin B; Maillasson M; Charrier C; Téletchéa S; Heymann D
Cytokine; 2015 Dec; 76(2):170-181. PubMed ID: 26095744
[TBL] [Abstract][Full Text] [Related]
10. IL-34 is a Treg-specific cytokine and mediates transplant tolerance.
Bézie S; Picarda E; Ossart J; Tesson L; Usal C; Renaudin K; Anegon I; Guillonneau C
J Clin Invest; 2015 Oct; 125(10):3952-64. PubMed ID: 26389674
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease.
Palmieri O; Creanza TM; Bossa F; Palumbo O; Maglietta R; Ancona N; Corritore G; Latiano T; Martino G; Biscaglia G; Scimeca D; De Petris MP; Carella M; Annese V; Andriulli A; Latiano A
Inflamm Bowel Dis; 2015 Jun; 21(6):1260-8. PubMed ID: 25901971
[TBL] [Abstract][Full Text] [Related]
12. Receptor-Type Protein-Tyrosine Phosphatase ζ and Colony Stimulating Factor-1 Receptor in the Intestine: Cellular Expression and Cytokine- and Chemokine Responses by Interleukin-34 and Colony Stimulating Factor-1.
Zwicker S; Bureik D; Bosma M; Martinez GL; Almer S; Boström EA
PLoS One; 2016; 11(11):e0167324. PubMed ID: 27898738
[TBL] [Abstract][Full Text] [Related]
13. Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation.
Wang Y; Bugatti M; Ulland TK; Vermi W; Gilfillan S; Colonna M
Eur J Immunol; 2016 Mar; 46(3):552-9. PubMed ID: 26634935
[TBL] [Abstract][Full Text] [Related]
14. IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease.
Baek JH; Zeng R; Weinmann-Menke J; Valerius MT; Wada Y; Ajay AK; Colonna M; Kelley VR
J Clin Invest; 2015 Aug; 125(8):3198-214. PubMed ID: 26121749
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-34 induces monocytic-like differentiation in leukemia cell lines.
Booker BE; Clark RS; Pellom ST; Adunyah SE
Int J Biochem Mol Biol; 2015; 6(1):1-16. PubMed ID: 26045972
[TBL] [Abstract][Full Text] [Related]
16. IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential.
Boulakirba S; Pfeifer A; Mhaidly R; Obba S; Goulard M; Schmitt T; Chaintreuil P; Calleja A; Furstoss N; Orange F; Lacas-Gervais S; Boyer L; Marchetti S; Verhoeyen E; Luciano F; Robert G; Auberger P; Jacquel A
Sci Rep; 2018 Jan; 8(1):256. PubMed ID: 29321503
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory properties of the cytokine IL-34.
Guillonneau C; Bézie S; Anegon I
Cell Mol Life Sci; 2017 Jul; 74(14):2569-2586. PubMed ID: 28258292
[TBL] [Abstract][Full Text] [Related]
18. CSF-1/CSF-1R targeting agents in clinical development for cancer therapy.
Ries CH; Hoves S; Cannarile MA; Rüttinger D
Curr Opin Pharmacol; 2015 Aug; 23():45-51. PubMed ID: 26051995
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effect of pectic polysaccharides extracted from Rauwolfia verticillata (Lour.) Baill.var.hainanensis Tsiang on inflammation by regulation of NF- κ B pathway and interleukin-17 in mice with dextran sulphatesodium-induced ulcerative colitis.
Miao XP; Sun XN; Cui LJ; Cao QF; Zhuang GF; Deng TZ; Zhang DY
Asian Pac J Trop Med; 2015 Feb; 8(2):147-52. PubMed ID: 25902030
[TBL] [Abstract][Full Text] [Related]
20. Validation of a modified model of TNBS-induced colitis in rats. How to induce a chemical colitis in rats.
Tomasello G; Sinagra E; Raimondo D; Palumbo VD; Puleio R; Cottone M; Damiani P; Traina G; Abruzzo A; Damiani F; Buscemi S; Noto M; Lo Monte AI
Acta Biomed; 2015 Apr; 86(1):92-6. PubMed ID: 25948034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
